TESOFENSINE

Tesofensine, a member of the phenyltropane drug family, operates as a serotonin–noradrenaline–dopamine reuptake inhibitor. Initially explored for treating Alzheimer’s and Parkinson’s diseases, it shifted its focus to combat obesity due to consistent weight loss reported as an adverse effect, especially in overweight or obese patients. Although early trials for other conditions showed limited efficacy, tesofensine demonstrated promise in weight loss.

As an appetite suppressant, tesofensine effectively aids in reducing food intake. Additionally, it elevates resting energy expenditure, contributing to its effectiveness. Successful completion of Phase II clinical trials has positioned tesofensine as a potential game-changer in the treatment of obesity.

500mcg $279.99         1-Month Supply

1000mcg $424.99       1-Month Supply

Buy more and save! 

500mcg  $599.99         3-Month Supply

1000mcg $999.99       3-Month Supply